Nanobacterium
March 22, 2010 by Staff
Filed under Health Conditions / Ailments
Nanobacteria (singular nanobacterium) is the name of a proposed class of living organisms; specifically cell-walled microorganisms with a size much smaller than the generally accepted lower limit size for life (about 200 nanometres for bacteria). Originally based on observed nano-scale structures in geological formations (including some meteorites), the status of nanobacteria is controversial, with some researchers suggesting they are a new class of living organisms capable of incorporating radiolabeled uridine, and others attributing to them a simpler, abiotic nature. One skeptic dubbed them "the cold fusion of microbiology", in reference to a notorious episode of erroneous science.
The term 'calcifying nanoparticles' (CNPs) has also been used as a conservative name regarding their possible status as a life form. The most recent research tends to agree that these structures exist, and probably replicate in some way. Their status as living entities is still hotly debated, though some researchers now claim that the case that they are nonliving crystalline particles is conclusively proven. In medicine, they have been implicated in the formation of both kidney stones and arterial plaque.
1981–2000
In 1981 Torella and Morita described very small cells called ultramicrobacteria. Defined as being smaller than 300 nm, by 1982 MacDonell and Hood found that some could pass through a 200 nm membrane. Early in 1989, geologist Robert L. Folk found what he later identified as nannobacteria (written with double "n"), that is, nanoparticles isolated from geological specimens in travertine from hot springs of Viterbo, Italy. Initially searching for a bacterial cause for travertine deposition, scanning electron microscope examination of the mineral where no bacteria were detectable revealed extremely small objects which appeared to be biological. His first oral presentation elicited what he called "mostly a stony silence", at the 1992 Geological Society of America's annual convention. He proposed that nanobacteria are the principal agents of precipitation of all minerals and crystals on Earth formed in liquid water, that they also cause all oxidation of metals, and that they are abundant in many biological specimens.
In 1996, NASA scientist David McKay published a study suggesting the existence of nanofossils — fossils of Martian nanobacteria — in ALH84001, a meteorite originating from Mars and found in Antarctica.
Nanobacterium sanguineum was proposed in 1998 as an explanation of certain kinds of pathologic calcification (apatite in kidney stones) by Finnish researcher Olavi Kajander and Turkish researcher Neva Ciftcioglu, working at the University of Kuopio in Finland. According to the researchers the particles self-replicated in microbiological culture, and the researchers further reported having identified DNA in these structures by staining.
A paper published in 2000 by a team led by an NIH scientist John Cisar further tested these ideas. It stated that what had previously been described as "self-replication" was a form of crystalline growth. The only DNA detected in his specimens was identified as coming from the bacteria Phyllobacterium mysinacearum, which is a common contaminant in PCR reactions.
Kajander and Ciftcioglu set up a company in Finland in 2000, Nanobac Oy, to market medical diagnostic kits for identifying nanobacteria to medical researchers, and develop prescription medical treatments for calcification-associated diseases. The company was absorbed in 2003 by Nanobac Pharmaceuticals, Inc., a publicly traded company in Tampa, Florida founded by nanobiotic developer Gary Mezo.
2001–present
In 2004 a Mayo Clinic team led by Franklin Cockerill, John Lieske, and Virginia M. Miller, reported to have isolated nanobacteria in diseased human arteries and kidney stones. Their results were published in 2004 and 2006 respectively. Similar findings were obtained in 2005 by László Puskás at the DNA Lab, University of Szeged, Hungary. Dr. Puskás identified these particles in cultures obtained from human atherosclerotic aortic walls and blood samples of atherosclerotic patients but the group was unable to detect DNA in these samples.
In 2005, Ciftcioglu and her research team at NASA used a rotating cell culture flask, which simulates some aspects of low-gravity conditions, to culture nanobacteria suspected of rapidly forming kidney stones in astronauts. In this environment, they were found to multiply five times faster than in normal Earth gravity. The study concluded that nanobacteria might have a potential role in forming kidney stones and may need to be screened for in crews pre-flight.
The February 2008 PLoS Pathogens article focused on the comprehensive characterization of nanobacteria. The authors say that their results rule out the existence of nanobacteria as living entities, instead revealing that they are a unique self-propagating entity and that they are self-propagating mineral-fetuin complexes.
An April 2008 PNAS article also reported that blood nanobacteria are not living organisms and stated that "CaCO3 precipitates prepared in vitro are remarkably similar to purported nanobacteria in terms of their uniformly sized, membrane-delineated vesicular shapes, with cellular division-like formations and aggregations in the form of colonies." The growth of such "biomorphic" inorganic precipitates was studied in detail in a 2009 Science paper, which showed that unusual crystal growth mechanisms can produce witherite precipitates from barium chloride and silica solutions that closely resemble primitive organisms. The authors commented on the close resemblance of these crystals to putative nanobacteria, stating that their results showed that evidence for life cannot rest on morphology alone.

